InSightec raises $59m, taps ex-Mako CEO Ferré for board

InSightec says it raised $59 million for its ExAblate fibroid device and named ex-Mako Surgical CEO Dr. Maurice Ferré as chairman of the board.

InSightec said today that it reeled in a $59 million Series D round from institutional investors in the U.S. and Asia and named Dr. Maurice Ferré as chairman of the board.

InSightec developed the ExAblate MR-guided ultrasound targeting technology.

InSightec Ltd

News Well, Funding Roundup, Personnel, Ultrasound

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Gp37Wy